4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-011242
Options or other derivatives
- Chief Scientific Officer acquired 41,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-02-16 | Grant or award · Stock option (right to buy) | +33,000 | 33,000 | D | ||
| Biller Scott Chief Scientific Officer | 2018-02-16 | Grant or award · Restricted stock units | +8,250 | 8,250 | D | ||
Loading xslF345X03/doc4.xml…